Literature DB >> 32197811

Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation.

Angus W Thomson1, Mohamed B Ezzelarab2.   

Abstract

Nonhuman primates (NHP) are important pre-clinical models for evaluation of the safety and efficacy of the most promising potential therapeutic advances in organ transplantation based on rodent studies. Although rare, dendritic cells (DC) play important roles in preservation of self tolerance and DC with immunoregulatory properties (regulatory DC; DCreg) can promote transplant tolerance in rodents when adoptively transferred to allograft recipients. NHP DCreg can be generated ex vivo from bone marrow precursors or blood monocytes of cynomolgus or rhesus macaques or baboons. NHP DCreg generated in the presence of anti-inflammatory factors that confer stability and resistance to maturation, subvert alloreactive T cell responses. When infused into rhesus renal allograft recipients before transplant, they safely prolong MHC mis-matched graft survival, associated with attenuation of anti-donor immune reactivity. In this concise review we describe the properties of NHP DCreg and discuss their influence on T cell responses, alloimmunity and organ transplant survival.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cells; Immune regulation; Nonhuman primates; Tolerance; Transplantation

Mesh:

Year:  2020        PMID: 32197811      PMCID: PMC7197030          DOI: 10.1016/j.cellimm.2020.104087

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  50 in total

1.  An in vitro evaluation of the potential suitability of peripheral blood CD14(+) and bone marrow CD34(+)-derived dendritic cells for a tolerance inducing regimen in the primate.

Authors:  Joanna Ashton-Chess; Gilles Blancho
Journal:  J Immunol Methods       Date:  2005-02       Impact factor: 2.303

Review 2.  Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model.

Authors:  Simon M Barratt-Boyes; Kevin N Brown; Nada Melhem; Adam C Soloff; Sherrianne M Gleason
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.

Authors:  F Fu; Y Li; S Qian; L Lu; F Chambers; T E Starzl; J J Fung; A W Thomson
Journal:  Transplantation       Date:  1996-09-15       Impact factor: 4.939

4.  Induction of tolerance by IL-10-treated dendritic cells.

Authors:  K Steinbrink; M Wölfl; H Jonuleit; J Knop; A H Enk
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

5.  Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.

Authors:  Ryosuke Ikeguchi; Justin M Sacks; Jignesh V Unadkat; Mario Solari; Elaine K Horibe; Angus W Thomson; Andrew W P Lee; Maryam Feili-Hariri
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

6.  Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.

Authors:  M B Ezzelarab; A F Zahorchak; L Lu; A E Morelli; G Chalasani; A J Demetris; F G Lakkis; M Wijkstrom; N Murase; A Humar; R Shapiro; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2013-06-11       Impact factor: 8.086

Review 7.  Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.

Authors:  Angus W Thomson; Abhinav Humar; Fadi G Lakkis; Diana M Metes
Journal:  Hum Immunol       Date:  2017-10-31       Impact factor: 2.850

8.  Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

Authors:  S Chandran; Q Tang; M Sarwal; Z G Laszik; A L Putnam; K Lee; J Leung; V Nguyen; T Sigdel; E C Tavares; J Y C Yang; M Hellerstein; M Fitch; J A Bluestone; F Vincenti
Journal:  Am J Transplant       Date:  2017-08-14       Impact factor: 8.086

9.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.

Authors:  Alberto Sánchez-Fueyo; Gavin Whitehouse; Nathali Grageda; Matthew E Cramp; Tiong Y Lim; Marco Romano; Sarah Thirkell; Katie Lowe; Laura Fry; Julie Heward; Alex Kerr; Jakia Ali; Chris Fisher; Gillian Lewis; Andrew Hope; Elisavet Kodela; Mike Lyne; Farzin Farzaneh; Shahram Kordasti; Irene Rebollo-Mesa; Juan Jose Lozano; Niloufar Safinia; Nigel Heaton; Robert Lechler; Marc Martínez-Llordella; Giovanna Lombardi
Journal:  Am J Transplant       Date:  2020-02-03       Impact factor: 8.086

View more
  2 in total

1.  Ultrasonographic study of hemodynamics and contrast-enhanced ultrasound in the rhesus monkey kidney.

Authors:  Hong Wang; Qipu Feng; Chao Li; Huan Zhang; Yulan Peng
Journal:  Exp Anim       Date:  2021-11-19

Review 2.  Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease.

Authors:  Sara Ness; Shiming Lin; John R Gordon
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.